#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroblastoma recurrent Fusarium infection Facioscapulohumeral muscular dystrophy Deafness Inborn error of metabolism Pneumonia Pericarditis Osteosarcoma Proteus syndrome Monogenic diabetes Becker's muscular dystrophy Kearns-Sayre syndrome Eosinophilic oesophagitis Homocystinuria Cholestatic pruritus More trials…

    Learn about Rare Diseases

    Phenylketonuria – Treatment Ornithine transcarbamoylase deficiency – Basic Information Richter’s syndrome – Basic Information Nodal marginal zone B-cell lymphoma – Trials in Disease Synovial sarcoma – Diagnostics Mucopolysaccharidosis – Diagnostics Adrenocortical carcinoma – Trials in Disease Lysosomal storage disorder – Trials in Disease Rhabdomyosarcoma recurrent – Diagnostics Bronchiolitis obliterans syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amiloride Diphenhydramine Hydrochloride Nimodipine [Al[18F]F]Fapi-74 Tafamidis Narsoplimab NALMEFENE HYDROCHLORIDE Progesterone, Micronised Islatravir IDROXIOLEIC ACID VANADIUM OXIDE SULFATE Atenolol Sotorasib Entinostat Chlorphenamine Maleate Choriogonadotropin Alfa Cat Epithelium Extract SODIUM HYDROXIDE Ivabradine Hydrochloride ACETYLCARNITINE HYDROCHLORIDE More therapies…

    Learn about Your Condition

    Neurodegenerative disorder Urethral stenosis Cartilage injury Androgenetic alopecia Dementia Angina pectoris Rett syndrome Hypochromic anaemia Carcinoid syndrome Peritoneal cancer index Viral myocarditis Metastatic malignant melanoma Encephalitis Japanese B Endometrial cancer stage III Wheezing More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Evangelismos S.A.

Evangelismos S.A.

Ipsiladou 45-47, Athens, 106 76, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Idecabtagene Vicleucel and Lenalidomide Maintenance Therapy for Adults with Newly Diagnosed Multiple Myeloma After Stem Cell Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Cyclophosphamide Monohydrate
    • Diphenhydramine Hydrochloride
    • Fludarabine Phosphate
    Austria Belgium Czechia Denmark France Germany +6

  • Study on the Effects of MBS2320 for Patients with Idiopathic Pulmonary Fibrosis (IPF)

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Mbs2320
    France Germany Greece Hungary Italy Spain

  • Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

    Not recruiting

    3 1
    Investigated Drugs:
    • Asundexian
    Austria Belgium Bulgaria Czechia Denmark Finland +14

  • Study on the Effectiveness of Weekly IcoSema (Insulin Icodec and Semaglutide) vs. Daily Insulin Glargine for Adults with Type 2 Diabetes Not Controlled by Oral Drugs

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Dapagliflozin
    • Insulin Glargine
    • Insulin Icodec
    Greece Italy Poland

  • Study on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Abatacept
    Cyprus Denmark France Germany Greece Ireland +3

  • Study on Seralutinib for Treating Pulmonary Arterial Hypertension in Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Seralutinib
    Austria Belgium Czechia Denmark France Germany +10

  • Study on the Effects of GSK3739937 for Adults with HIV-1 Who Have Not Yet Received Treatment

    Not recruiting

    2 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Gsk3739937
    Greece Italy Poland Spain

  • Study on Long-Term Safety and Effectiveness of Upadacitinib for Patients with Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Upadacitinib
    Austria Belgium Croatia Czechia Estonia Finland +14

  • Study of Bepirovirsen for Patients with Chronic Hepatitis B on Nucleos(t)ide Analogue Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic hepatitis B
    • Hepatitis B
    Investigated Drugs:
    • Bepirovirsen
    Bulgaria France Germany Greece Hungary Italy +3

  • Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Lung disorder
    Investigated Drugs:
    • Baricitinib
    Austria Belgium Czechia France Germany Greece +8
Previous Page
1 … 10 11 12 13 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!